Precision BioSciences raises $25.6 mln
Precision BioScience said Monday it closed a $25.6 million Series A round led by venBIO. Fidelity Biosciences, Amgen Ventures, Baxter Ventures, Osage University Partners, the Longevity Fund, and two well-known public market investors also participated. Research Triangle Park, North Carolina-based Precision BioSciences is a genome editing company.
11 May 2015•3 mins read
